Zoono Group Limited, together with its subsidiaries, engages in the research, development, and sale of a range of antimicrobial products in New Zealand and internationally.
Price History & Performance
|Historical stock prices|
|Current Share Price||AU$0.47|
|52 Week High||AU$0.38|
|52 Week Low||AU$1.76|
|1 Month Change||1.06%|
|3 Month Change||-34.93%|
|1 Year Change||-67.24%|
|3 Year Change||375.00%|
|5 Year Change||n/a|
|Change since IPO||163.89%|
Recent News & Updates
Returns On Capital Are A Standout For Zoono Group (ASX:ZNO)
What are the early trends we should look for to identify a stock that could multiply in value over the long term...
Positive Sentiment Still Eludes Zoono Group Limited (ASX:ZNO) Following 27% Share Price Slump
To the annoyance of some shareholders, Zoono Group Limited ( ASX:ZNO ) shares are down a considerable 27% in the last...
Calculating The Intrinsic Value Of Zoono Group Limited (ASX:ZNO)
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Zoono Group Limited...
|ZNO||AU Chemicals||AU Market|
Return vs Industry: ZNO underperformed the Australian Chemicals industry which returned 11.3% over the past year.
Return vs Market: ZNO underperformed the Australian Market which returned 20.2% over the past year.
Stable Share Price: ZNO is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 11% a week.
Volatility Over Time: ZNO's weekly volatility (11%) has been stable over the past year.
About the Company
Zoono Group Limited, together with its subsidiaries, engages in the research, development, and sale of a range of antimicrobial products in New Zealand and internationally. Its products include hand sanitizers, textile applicators, mold remediation, and surface sanitizers. The company serves airlines, manufacturing, healthcare, childcare, and other industries.
Zoono Group Fundamentals Summary
|ZNO fundamental statistics|
Is ZNO overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|ZNO income statement (TTM)|
|Cost of Revenue||NZ$11.03m|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
|Earnings per share (EPS)||0.029|
|Net Profit Margin||17.44%|
How did ZNO perform over the long term?See historical performance and comparison
6.4%Current Dividend Yield
Is Zoono Group undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: ZNO (A$0.48) is trading below our estimate of fair value (A$0.51)
Significantly Below Fair Value: ZNO is trading below fair value, but not by a significant amount.
Price To Earnings Ratio
PE vs Industry: ZNO is good value based on its PE Ratio (17.4x) compared to the Australian Chemicals industry average (62x).
PE vs Market: ZNO is good value based on its PE Ratio (17.4x) compared to the Australian market (19.8x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate ZNO's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: ZNO's PB Ratio (3.9x) is in line with the AU Chemicals industry average.
How is Zoono Group forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Materials industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Zoono Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Zoono Group performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: ZNO has a high level of non-cash earnings.
Growing Profit Margin: ZNO's current net profit margins (17.4%) are lower than last year (43.5%).
Past Earnings Growth Analysis
Earnings Trend: ZNO has become profitable over the past 5 years, growing earnings by 70.4% per year.
Accelerating Growth: ZNO's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: ZNO had negative earnings growth (-71.6%) over the past year, making it difficult to compare to the Chemicals industry average (-61.8%).
Return on Equity
High ROE: ZNO's Return on Equity (22%) is considered high.
How is Zoono Group's financial position?
Financial Position Analysis
Short Term Liabilities: ZNO's short term assets (NZ$23.3M) exceed its short term liabilities (NZ$3.3M).
Long Term Liabilities: ZNO's short term assets (NZ$23.3M) exceed its long term liabilities (NZ$7.3M).
Debt to Equity History and Analysis
Debt Level: ZNO is debt free.
Reducing Debt: ZNO currently has no debt however we can't compare to 5 years ago as we have no data for that period.
Debt Coverage: ZNO has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: ZNO has no debt, therefore coverage of interest payments is not a concern.
What is Zoono Group current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: ZNO's dividend (6.44%) is higher than the bottom 25% of dividend payers in the Australian market (2.27%).
High Dividend: ZNO's dividend (6.44%) is in the top 25% of dividend payers in the Australian market (5.32%)
Stability and Growth of Payments
Stable Dividend: Too early to tell whether ZNO's dividend payments have been stable as they only just started paying a dividend.
Growing Dividend: Too early to tell if ZNO's dividend payments are increasing as they only just started paying a dividend.
Current Payout to Shareholders
Dividend Coverage: With its high payout ratio (110.7%), ZNO's dividend payments are not well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Mr. Paul Hyslop has been the Managing Director and Director of Zoono Group Limited since April 26, 2017 and serves as its Chief Executive Officer. Mr. Hyslop's primary responsibility is to determine the st...
CEO Compensation Analysis
Compensation vs Market: Paul's total compensation ($USD339.61K) is about average for companies of similar size in the Australian market ($USD302.72K).
Compensation vs Earnings: Paul's compensation has been consistent with company performance over the past year.
Experienced Management: ZNO's management team is considered experienced (4.4 years average tenure).
Experienced Board: ZNO's board of directors are considered experienced (4.5 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Zoono Group Limited's employee growth, exchange listings and data sources
- Name: Zoono Group Limited
- Ticker: ZNO
- Exchange: ASX
- Founded: 1986
- Industry: Specialty Chemicals
- Sector: Materials
- Market Cap: AU$76.044m
- Shares outstanding: 165.31m
- Website: https://zoono.com
- Zoono Group Limited
- 24 Bishop Dunn Place
- Botany South
- New Zealand
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/10/18 07:05|
|End of Day Share Price||2021/10/18 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.